Medical Equipment

Global Drug Screening Market Analysis 2025–2029: Opportunities for Strategic Growth

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#How Much Was The Drug Screening Market Worth In 2025, And What Is Its Anticipated Value By 2029?#_x000D_

The sector for drug screening has experienced swift expansion over the last few years, projected to increase its valuation from $8.57 billion in 2024 to $9.72 billion come 2025, signifying a compounded annual growth rate of 13.3%. This upward trajectory observed during the past period is fueled by numerous factors, including pharmaceutical drug evaluation processes, advancements in healthcare and laboratory diagnostics, the expansion of substance misuse rehabilitation services, greater financial allocations toward research initiatives, and the wider adoption of various drug testing instruments and kits._x000D_

_x000D_

Anticipating substantial expansion in the coming years, the domain of drug screening is projected to reach a valuation of $16.86 billion by 2029, driven by a compound annual growth rate (CAGR) of 14.8%; this upward trajectory across the forecast horizon is fueled by several key factors, notably the growing permissiveness surrounding cannabis, the ongoing opioid epidemic, a rise in the number of sporting competitions, the proliferation of rapid and point-of-care diagnostic methods, evolving governmental mandates and compliance frameworks regarding substance use, the development of employee health and wellness initiatives, and the broadening reach into global territories._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp_x000D_

_x000D_

#What Are The Drivers Pushing New Developments In The Drug Screening Market?#_x000D_

The escalating prevalence of substance abuse involving both illicit drugs and alcohol is anticipated to be a primary impetus behind the future expansion of the drug screening industry. Drug addiction, fundamentally a disorder impacting neurological function and conduct, manifests as an inability to manage the intake of prescription medications or illicit narcotics; this category also encompasses substances like nicotine and marijuana. The rise in dependency on these substances correlates directly with heightened disease incidence, thereby necessitating increased drug testing protocols. To illustrate this trend, global concerns regarding substance utilization remained notably high in 2022. Data presented by the National Survey on Drug Use and Health (NSDUH) pointed out that in the United States, 13.5% of individuals aged twelve and above reported substance use in the preceding month, representing a year-over-year uptick of 3.8%. Furthermore, a significant portion, specifically 59.277 million people, equating to 21.4% of those aged twelve years or more, admitted to using illegal substances or misusing prescribed drugs within the last year. Compounding this situation, the ramifications of the recent pandemic saw the risks associated with drug use amplified, evidenced by up to a fourfold surge in cannabis consumption among younger populations in specific global regions. Consequently, this pervasive upward trajectory in the consumption of intoxicants and drugs is directly fueling the market’s anticipated growth throughout the forecast tenure._x000D_

_x000D_

#How Is The Drug Screening Market Classified Into Different Segments?#_x000D_

The drug screeningmarket covered in this report is segmented – _x000D_

_x000D_

1) By Products: Rapid Testing Devices, Consumables, Other Products_x000D_

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types_x000D_

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges_x000D_

_x000D_

Subsegments:_x000D_

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips _x000D_

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards _x000D_

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions_x000D_

_x000D_

#How Are Emerging Market Trends Shaping The Drug Screening Industry Landscape?#_x000D_

A significant trend currently observed within the drug screening market involves the introduction of novel solutions, with leading market participants prioritizing the creation and release of cutting-edge offerings to satisfy escalating industry needs and enhance their competitive standing; furthermore, the implications of the COVID-19 pandemic instigated an abrupt shift in how drug screening is managed, consequently altering established testing procedures and stimulating greater corporate endeavors toward invention and the creation of fresh products, as firms endeavor to engineer superior, universally applicable drug testing mechanisms for laboratories; as an illustration of this, in September 2022, Japan’s Sysmex Corporation unveiled the UF-1500 Fully Automated Urine Particle Testing Analyzer, a new device designed for urine sediment analysis and screening, which retains the high operational capability and user-friendliness characteristic of their premier urine sediment testing instrument, the UF-5000, whilst concurrently achieving a more compact physical size compared to its predecessor._x000D_

_x000D_

#Who Are The Top Performing Companies In The Drug Screening Market In Recent Years?#_x000D_

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report_x000D_

_x000D_

#Which Region Currently Holds The Largest Share Of The Drug Screening Market?#_x000D_

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Drug Screening Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Drug Screening Market 2025, By The Business Research Company#_x000D_

_x000D_

Data Protection As A Service Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report_x000D_

_x000D_

Cloud Security Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report_x000D_

_x000D_